Amplifon maps its long-term strategy, shares in a growing hearing care market

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-27, 12:51.

Amplifon (IT0004056880) continues to execute on a long-term growth strategy in global hearing care retail. The Milan-listed group positions itself in a structurally expanding market, with demand supported by aging populations and rising penetration of hearing aids according to sector studies.

How Amplifon plans to grow

Amplifon describes its strategy around three pillars: portfolio expansion, customer experience and organizational efficiency, as summarized in its latest corporate presentation.Company investor presentation The group focuses on organic growth through new hearing care points of sale and selected bolt-on acquisitions in key markets such as Europe, North America and Asia-Pacific.

The company highlights investments in marketing, digital channels and clinical protocols to attract and retain customers across its brands, which include Amplifon and Miracle-Ear.Miracle-Ear brand information Management sees benefits from scale in procurement and back-office functions, which are intended to support margins over the medium term.

A structurally growing hearing care market

Independent market research points to a growing global hearing aids market, with estimates in the tens of billions of US dollars and mid-single to high-single digit annual growth rates over the next several years, driven by demographics and greater awareness of hearing health.Reuters analysis on hearing aid demand Amplifon operates as a retailer and service provider in this space, while manufacturers such as Sonova and Demant supply much of the underlying hardware.

In Europe, Amplifon competes with regional and local chains, but benefits from its international footprint and recognized brand, especially in markets like Italy, France and Germany where it runs dense networks of hearing care centers.Sonova investor information In North America, the group leverages the Miracle-Ear franchise model to extend its reach in the United States.

What the company sells

Amplifon’s core business is the distribution and fitting of hearing aids and related services, with products sourced from several major manufacturers and complemented by its own private-label offerings in selected markets.Amplifon business overview Customers receive hearing tests, device selection, personalized fitting and aftercare support through the company’s retail network.

Where the stock trades today

Amplifon shares (IT0004056880) trade on Borsa Italiana in Milan; the latest available price information is published by the exchange and financial data providers during regular trading hours.

This article is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any securities. All data are based on publicly available sources and may change over time.